Pages that link to "Item:Q5757865"
From MaRDI portal
The following pages link to Response-Adaptive Randomization for Survival Trials: The Parametric Approach (Q5757865):
Displayed 12 items.
- Implementing optimal allocation in clinical trials with multiple endpoints (Q729721) (← links)
- Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity (Q746098) (← links)
- Optimal response and covariate-adaptive biased-coin designs for clinical trials with continuous multivariate or longitudinal responses (Q1658168) (← links)
- Optimal designs for testing the efficacy of heterogeneous experimental groups (Q2044412) (← links)
- Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses (Q2157495) (← links)
- Sequential monitoring of response-adaptive randomized clinical trials with sample size re-estimation (Q2301050) (← links)
- Group-sequential response-adaptive designs for censored survival outcomes (Q2301063) (← links)
- On optimal designs for clinical trials: an updated review (Q2301225) (← links)
- Adaptive Randomization for Multiarm Comparative Clinical Trials Based on Joint Efficacy/Toxicity Outcomes (Q3183237) (← links)
- An optimal multiarmed response adaptive design for survival outcome with independent censoring (Q6068333) (← links)
- Covariate-adjusted response-adaptive designs for censored survival responses (Q6101701) (← links)
- Response-adaptive randomization in clinical trials: from myths to practical considerations (Q6166866) (← links)